Semaglutide
GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin signalling research.
View Semaglutide recordCombination reference material of cagrilintide and semaglutide supplied for in-vitro incretin and amylin signalling research.
| Standard product name | Cagrisema |
|---|---|
| CAS number | Not published on this site |
| Published HPLC purity | Not published on this site |
| Category | Incretin Receptor Agonists |
| Available specifications | 5 mg (2.5 mg + 2.5 mg) |
| Molecular formula | Not published on this site |
| Sequence | Not published on this site |
| Certificate of analysis | Not published on this site. Request available batch documentation from the research desk. |
| Ordering | Inquiry only — no price is published |
Combination reference material of cagrilintide and semaglutide supplied for in-vitro incretin and amylin signalling research.
A CAS number is not published for Cagrisema on this site. Our published product record lists identity documentation as available on request from the research desk.
A numeric purity value is not published for Cagrisema on this page. Purity documentation for the supplied lot is requested through the research desk.
The catalog lists Cagrisema as 5 mg (2.5 mg + 2.5 mg) in the Incretin Receptor Agonists category. Confirm current availability with the research desk before planning an order.
A certificate of analysis (COA) is not published for Cagrisema on this site. Batch documentation that exists for a specific lot is released through the research desk on request; no certificate is generated for products without one.
This catalog is inquiry-based and does not publish prices. Send Cagrisema, the quantity, and the delivery country to the research desk on WhatsApp (+852 44597169) to receive availability and pricing.
Shipping and handling terms are described on the shipping page. See https://novaplexlabs.com/shipping.html for the published shipping information.
GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin signalling research.
View Semaglutide recordDual GIP and GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin receptor research.
View Tirzepatide recordTriple GIP, GLP-1 and glucagon receptor agonist reference material supplied as a lyophilized powder for in-vitro receptor research.
View Retatrutide recordDual GLP-1 and glucagon receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin research.
View Mazdutide record